Alpha Teknova, Inc.

NASDAQ:TKNO

Drug Manufacturers - Specialty & Generic

Healthcare
$7.88 +4.55%

+$0.23 today

Market cap
$495.68M
Beta
0.63
P/E (TTM)
-16.2
EPS (TTM)
-$0.32
52W Low $1.91High $6.68

Volume 0.30M

Average 0.13M

TKNO Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Alpha Teknova, Inc.NASDAQ: TKNO

Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026

Accumulated OCI remains negative

Q1 FY2026 Accumulated OCI was $0, compared with $0 a year earlier.

Context

  • Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Accumulated OCI increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Accumulated OCI vs competitors

How TKNO compares with its peers on the latest reported figures

  • TKNO's Mar 2026 Accumulated OCI of $0 is the 2nd highest of the 8 companies compared; the peer median is -$3.36M.
  • Accumulated OCI amounts to 0.0% of total assets for TKNO, versus a peer median of 0.7%.
TKNO Competitors Peer median
Accumulated OCI for TKNO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$459K -20.0%—0.1%
TKNOAlpha Teknova, Inc.Mar 2026$0 ——0.0%
BLFSBioLife Solutions, Inc.Mar 2026-$120K -463.6%—0.0%
LABStandard BioTools Inc.Mar 2026-$511K -143.7%—0.1%
MLABMesa Laboratories, Inc.Mar 2026-$3.36M +65.7%—0.8%
RGENRepligen CorporationJun 2026-$19.79M -1053.0%—0.7%
TECHBio-Techne CorporationSep 2026-$71.2M -10.6%—2.7%
AZTAAzenta, Inc.Sep 2026-$77.4M -248.4%—4.5%
Peer median (excluding TKNO) -$3.36M-143.7%—0.7%

Competitors are the stored peer set for TKNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents87.52M42.24M28.48M3.71M5.91M
Short-term Investments00026.69M0
Net Receivables5.85M4.28M3.95M4.31M4.62M
Inventory5.39M12.25M11.59M6.8M7.05M
Other Current Assets001.63M1.27M16.93M
Total Current Assets101.2M61.14M45.66M42.78M34.51M
Property, Plant & Equipment (Net)29.81M71.31M66.84M61.52M55.85M
Goodwill16.61M0000
Intangible Assets18.7M17.56M14.24M13.09M11.94M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets180K2.25M1.85M1.38M1.29M
Total Non-current Assets65.31M91.12M82.93M75.99M69.07M
Total Assets166.51M152.26M128.59M118.77M103.58M
Account Payables2.25M2.45M1.49M825K1.38M
Short-term Debt0004.05M1.88M
Tax Payables00000
Deferred Revenue200K198K16K30K0
Other Current Liabilities00004.28M
Total Current Liabilities7.74M10.88M8.88M11.21M7.54M
Long-term Debt11.87M21.98M13.25M9.44M13.27M
Deferred Tax Liabilities3.15M1.22M919K827K879K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities542K191K102K10K13.12M
Total Non-current Liabilities15.57M41.5M29.68M25.16M27.27M
Total Liabilities23.31M52.38M38.55M36.38M34.81M
Common Stock0001K1K
Retained Earnings(7.54M)(55.01M)(91.79M)(118.53M)(135.79M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity143.2M99.89M90.04M82.39M68.78M
Total Debt11.87M42.31M30.46M30.17M15.15M
Net Debt(75.65M)74K1.97M26.46M9.23M

Alpha Teknova, Inc.

NASDAQ:TKNO

Intrinsic Alpha fair value

Locked

Current Price

$7.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.